(Q43005382)

English

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

scientific article published in August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study (English)

1 reference

Europe PubMed Central

12 November 2017

pain management

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christine Rauschkolb

5

object named as

Christine Rauschkolb

1 reference

Europe PubMed Central

12 November 2017

author name string

Robert Buynak

1

1 reference

Europe PubMed Central

12 November 2017

Douglas Y Shapiro

2

1 reference

Europe PubMed Central

12 November 2017

Akiko Okamoto

3

1 reference

Europe PubMed Central

12 November 2017

Ilse Van Hove

4

1 reference

Europe PubMed Central

12 November 2017

Achim Steup

6

1 reference

Europe PubMed Central

12 November 2017

Bernd Lange

7

1 reference

Europe PubMed Central

12 November 2017

Claudia Lange

8

1 reference

Europe PubMed Central

12 November 2017

Mila Etropolski

9

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 August 2010

1 reference

Europe PubMed Central

12 November 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

12 November 2017

11

1 reference

Europe PubMed Central

12 November 2017

1787-1804

1 reference

Europe PubMed Central

12 November 2017

11

1 reference

Europe PubMed Central

12 November 2017

painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Evidence for and against the use of opioid analgesics for chronic nonmalignant low back pain: a review

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Evidence-informed management of chronic low back pain with opioid analgesics

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Opioid effectiveness and side effects in chronic pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Responsible prescribing of opioids for the management of chronic pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Incidence, prevalence, and management of opioid bowel dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Management of opioid-induced constipation

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Tapentadol Hydrochloride

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-cont

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Development of a sleep diary for chronic pain patients.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

The Clinical Opiate Withdrawal Scale (COWS).

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Pharmacological aspects of the effects of tramadol on G-protein coupled receptors

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

A risk-benefit assessment of tramadol in the management of pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Persistent pain and well-being: a World Health Organization Study in Primary Care.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Management of chronic pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

The evaluation of neuropathic components in low back pain

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

What is new in neuropathic pain?

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.497720

21 January 2018

Identifiers

10.1517/14656566.2010.497720

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43005382&oldid=1976493049"